Abstract
Opioid use disorder presents an increased risk of complications in pregnancy, particularly when untreated. To optimize outcomes, medication-assisted treatment using methadone or buprenorphine as a part of a comprehensive care model is recommended. Neonatal abstinence syndrome and poor fetal growth remain significant complications of this disorder despite maternal treatment.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 201-216 |
| Number of pages | 16 |
| Journal | Obstetrics and Gynecology Clinics of North America |
| Volume | 45 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jun 2018 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Buprenorphine
- Methadone
- Neonatal abstinence syndrome
- Opioid use disorder
- Pregnancy
Fingerprint
Dive into the research topics of 'Opioid Use Disorders and Pregnancy'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS